National Institutes of Health Neurological Institute
P.O. Box 5801
Bethesda, MD 20824
Telephone: 301-496-5751
Telephone: 1-800-352-9424

December 13, 1995 Press Release: NIH Announces Emergency Treatment for Stroke

To Request Full Text Copies:
National Institute of Neurological Disorders and Stroke
Building 31, Room 8A-1631 Center Drive MSC 2540
Bethesda, Maryland 20892-2540
(301) 496-5751

NEJM Original Article: Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group. "Tissue Plasminogen Activator for Acute Ischemic Stroke." The New England Journal of Medicine, Vol. 333, No. 24, pp. 1581-1587.

JAMA Original Article: New Era for Acute Stroke Treatment

Marwick, Charles, "New Era for Acute Stroke Treatment" (JAMA. 1997;277:199-200)

AMA Journal STROKE: Current and Prior Issues

Stroke: A Journal of Cerebral Circulation
Editor: Mark L. Dyken, Jr., MD
ISSN: 0039-2499

Thrombolysis for Stroke

Martin M. Pincus MD, PhD, "Thrombolysis for Stroke" (JAMA. 1997;277(1):19-20) & Responses

Archives of Neurology Archive: Conditions that Mimic Stroke in the Emergency Department

Richard B. Libman, MD, FRCPC; Elzbieta Wirkowski, MD; Jose Alvir, DrPH; T. Hemanth Rao, MD "Conditions That Mimic Stroke in the Emergency Department: Implications for Acute Stroke Trials" (Arch Neurol. 1995;52:1119-1122)

JAMA Abstracts Oct. 4, 1995: Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke

Werner Hacke, MD; Markku Kaste, MD; Cesare Fieschi, MD; Danilo Toni, MD; Emmanuel Lesaffre, PhD; Ruediger von Kummer, MD; Gudrun Boysen, MD; Erich Bluhmki, BSC; Godehard Hoexter, BSc; Marie-Helene Mahagne, MD; Michael Hennerici, MD; for the ECASS Study Group, "Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke: The European Cooperative Acute Stroke Study (ECASS)" (JAMA. 1995;274:1017-1025)

Archives of Neurology Abstracts: Progressing Neurological Deficit Secondary to Acute Ischemic Stroke

Danilo Toni, MD, PhD; Marco Fiorelli, MD, PhD; Mara Gentile, MD; Stefano Bastianello, MD, PhD; Maria Luisa Sacchetti, MD; Corrado Argentino, MD; Carlo Pozzilli, MD, PhD; Cesare Fieschi, MD, "Progressing Neurological Deficit Secondary to Acute Ischemic Stroke: A Study on Predictability, Pathogenesis, and Prognosis" (Arch Neurol. 1995;52:670-675)

Archives of Neurology July,1996: Traditional Risk Factors and Ischemic Stroke in Young Adults: The Baltimore-Washington Cooperative Young Stroke Study

Jennifer Rohr; Steven Kittner, MD, MPH; Barbara Feeser, MPH, MBA; J. Richard Hebel, PhD; Marsha-Gaye Whyte; Alyse Weinstein, MA; Norma Kanarak, PhD; David Buchholz, MD; Christopher Earley, MD, PhD; Constance Johnson, MD; Richard Macko, MD; Thomas Price, MD; Michael Sloan, MD; Barney Stern, MD; Robert Wityk, MD; Marcella Wozniak, MD, PhD; Roger Sherwin, MB, BChir, "Traditional Risk Factors and Ischemic Stroke in Young Adults: The Baltimore-Washington CooperativeYoung Stroke Study" (Arch Neurol. 1996;53:603-607)

Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration

Geoffrey A. Donnan, MD; Stephen M. Davis, MD; Brian R. Chambers, MD; Peter C. Gates, MBBS; Graeme J. Hankey, MD; John J. McNeil, PhD; David Rosen, PhD; Edward G. Stewart-Wynne, MBBS; Roger R. Tuck, PhD; for the Australian Streptokinase (ASK) Trial Study Group, "Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration" (JAMA. 1996;276:961-966)

Title Page